jamiebell

36 POSTS 0 COMMENTS

Medtronic names Laura Mauri as new chief scientific, medical and regulatory...

Medtronic has announced that Laura Mauri has been appointed as the company’s chief scientific, medical and regulatory officer. This appointment adds to Mauri's prior responsibilities...

Corindus relocates Massachusetts headquarters to accommodate company growth

Corindus, a Siemens Healthineers company, announced today the opening of its new headquarters at 275 Grove Street in Newton, USA. Siemens Healthineers relocated the...

Synchron announces long-term safety results with Stentrode device for severe paralysis

synchron stentrode safety
Synchron has announced the results from a study in which four people with amyotrophic lateral sclerosis (ALS) received an implant of the company’s Stentrode...

Nipro to bring Cronus high-pressure PTA balloon catheter to USA

Nipro Medical Corporation is set to introduce its second-generation Cronus high-pressure (HP) percutaneous transluminal angioplasty (PTA) balloon catheter to the US market. Cronus HP is...

Implantable brain-computer interface enables completely locked-in patient to communicate

Researchers at the Wyss Center for Bio and Neuroengineering (Geneva, Switzerland), in collaboration with the University of Tübingen (Tübingen, Germany), have enabled a person...

A closer look at new technologies in malignant ureteric obstruction

Malignant ureteric obstruction (MUO) poses several tangible threats to cancer patients—and these threats translate, in turn, to challenges for the interventional radiologist and other...

Fist Assist Devices announces Australian distribution deal and sales launch

fist assist devices fa-1
Fist Assist Devices has announced a three-year affiliation with Regional Health Care Group to commercialise and launch sales of the Fist Assist Model FA-1...

Largest real-world experience to date with VasQ device indicates long-term benefits...

The VasQ external support device (Laminate Medical) has demonstrated long-term benefits for radiocephalic (forearm) arteriovenous fistula (AVF) creation in a retrospective analysis of 150...

Perfuze raises €22.5m in Series A funding for novel acute ischaemic...

Perfuze announced today that it has closed a €22.5 million Series A investment round—the proceeds from which will be used to drive the next...

Shifting paradigms in diagnosing and treating small renal masses

In light of recent and upcoming developments in the space, Vinson Wai-Shun Chan and Tze Min Wah (Leeds, UK) explore the evidence and latest...

Mechanical thrombectomy shown to restore more function than medication alone following...

A new study from Japan has become the first randomised controlled trial (RCT) to demonstrate the effectiveness of endovascular mechanical thrombectomy procedures in patients...

Cerenovus launches Emboguard balloon guide catheter for acute ischaemic stroke

Cerenovus—a neurovascular firm that forms part of Johnson & Johnson Medical Devices Companies—has announced the launch of Emboguard, its next-generation balloon guide catheter to...

NovaGuide intelligent ultrasound found to significantly improve right-to-left shunt detection

NovaSignal Corporation has announced the results of a multicentre, prospective, single-arm study indicating that the company’s autonomous NovaGuide intelligent ultrasound is three times more...

Imperative launches Zoom POD aspiration tubing for use in stroke treatments

imperative zoom pod
Imperative Care has announced the launch of its Zoom POD aspiration tubing—the company’s latest innovation in elevating stroke care. This is the newest addition...

ISC 2022: Global EXCELLENT study “shows how much stroke thrombectomy has...

Mechanical removal of blood clots reduced post-stroke disability in nearly half of “all-comer” real-world stroke patients in a global study, according to preliminary late-breaking...

FDA issues two final guidances for including patient perspectives in medical...

The US Food and Drug Administration (FDA) has issued two final guidances providing recommendations for including patient perspectives in medical device clinical studies.   As...

IMPRESSION trial assessing MagicTouch AVF passes 50% enrolment

Concept Medical has shared the latest update from its IMPRESSION (Sirolimus-coated balloon angioplasty versus plain balloon angioplasty in the treatment of dialysis access dysfunction)...

Fist Assist receives FDA Breakthrough Device designation for wearable vein dilation...

fist assist devices fda
Fist Assist Devices has announced that it recently received Breakthrough Device designation from the US Food and Drug Administration (FDA) for its Fist Assist...

Arrow recalls percutaneous thrombolytic device kits over risk of separation

Arrow International has recalled its Arrow-Trerotola over-the-wire 7Fr percutaneous thrombolytic device (PTD) kits, which are used to remove clots in adult patients who have...

Amplifi vein dilation system demonstrates “encouraging” clinical results in haemodialysis access

artio medical
Artio Medical has announced that full results from its first-in-human clinical study of the Amplifi vein dilation system were presented at the 2021 VEITHSymposium...

The Holmium Platform: Three integrated products delivering individualised SIRT at its...

This educational supplement, sponsored by Terumo Interventional Systems, is intended for readers in Europe only. Highlights: Ana Oliveira (Centro Hospitalar Universitário de São João, Porto,...

Rapid Medical to initiate trial expanding thrombectomy treatment across distal regions...

rapid medical distals study
Rapid Medical today announced US Food and Drug Administration (FDA) investigational device exemption (IDE) approval for what it claims is the first-ever trial to...

Benefits of percutaneous fistula creation further bolstered by five-year Ellipsys data

ellipsys five-year data
The Ellipsys vascular access system (Avenu Medical/Medtronic) can be used to easily and safely create durable percutaneous arteriovenous fistulas (pAVFs) for haemodialysis—with new, long-term...

Medtronic unveils data on hypertension treatment preferences, launches SPYRAL AFFIRM study

Medtronic today announced findings from a new study of patient preferences for the treatment of hypertension. The findings are set to be presented during...

“Very encouraging” 12-month data from WRAPSODY FIRST study presented at CIRSE...

wrapsody first study
Twelve-month results from a first-in-human study of the Wrapsody cell-impermeable endoprosthesis (Merit Medical Systems) for the treatment of access circuit stenosis in haemodialysis patients...

Results from first-in-human study of Amplifi vein dilation system presented at...

amplifi viva 2021
Preliminary clinical results from a first-in-human study assessing the Amplifi vein dilation system (Artio Medical) were presented at Vascular Interventional Advances (VIVA) 2021 (5–7 October...

Medtronic receives CE mark approval for radial artery access portfolio

Medtronic receives CE mark approval for radial artery access portfolio
Medtronic today announced it has received CE mark approval for its radial artery access portfolio, which includes the Rist radial access selective catheter and the Rist...

Phenox highlights benefits of longer stentriever devices with new study results

phenox longer stentriever
Following its acceptance into Frontiers in Neurology, Phenox has announced the results of a paper exploring the benefit of choosing a longer stentriever for...

SNIS 2021: Remote stroke interventions raise several unique ethical challenges

remote stroke interventions
At the Society of NeuroInterventional Surgery’s 18th annual meeting (SNIS; July 26–29 2021, Colorado Springs, USA and virtual), Jeffrey Saver, professor of Neurology at...

Artio Medical completes enrolment of first-in-human trial investigating Amplifi vein dilation...

amplifi vein dilation system
Artio Medical announced today it has completed enrolment in its first-in-human study evaluating the Amplifi vein dilation system. In the study, five patients were treated...

Study shows increased risk of renal failure following lytic therapy for...

A large, single-centre retrospective study has revealed the risk of acute kidney injury (AKI) following pharmacomechanical thrombolysis (PMT) for lower extremity deep vein thrombosis...

Avicenna.AI receives CE Mark for AI tool to assess stroke severity

stroke severity assessment ai
Medical imaging AI specialist Avicenna.AI has received CE mark certification for its CINA ASPECTS AI tool for stroke severity assessment. CINA ASPECTS automatically processes...

More mixed results for DCBs in AV access maintenance as evidence...

trerotola misra tan av access dcbs drug coated balloons
Additional randomised controlled data regarding the effectiveness of drug-coated balloons (DCBs) in maintaining arteriovenous (AV) access offers new evidence, but it is freighted with...

Bifurcated T-stent reconstruction is safe and effective treatment for HVOO in...

dillon brown bifurcated t-stent reconstruction
A study has found that bifurcated T-stent reconstruction offers a safe and effective treatment option for hepatic venous outflow obstruction (HVOO) with anastomotic stenoses...

Results of two-year study show Zilver Vena Venous Stent is safe...

zilver vena venous stent vivo clinical study
The results of a two-year study support the continued safety and effectiveness of the Zilver Vena Venous Stent (Cook Medical) in treating symptomatic iliofemoral...

Fluoroscopically-guided insertion of td-CVC found to be “low exposure”, despite large...

td-cvc dialysis
While there is large variability based on the site of insertion, patient characteristics and previous accesses, fluoroscopically-guided insertion of tunnelled central venous catheters (td-CVC)...